Table 2.
Comparison of laboratory data of patients with TBE and co-infections (TBE + LD) compared to healthy subjects. Values are means ± SD.
| Normal range | Control Group | TBE | TBE + LD/HGA | |
|---|---|---|---|---|
| At admission | At admission | |||
| Complete blood count | ||||
| WBC [103/μL] | 4.00–10.00 | 6.35 ± 0.97 | 10.09 ± 2 | 7.27 ± 1.36 |
| Neutrophils [%] | 40.0–72.0 | – | 70.8 ± 9.50 | 60.33 ± 7.07 |
| Lymphocytes [%] | 18.0–48.0 | – | 18.48 ± 8.02 | 27.37 ± 6.11 |
| Monocytes [%] | 2.50–10.00 | – | 9.55 ± 2.8 | 10.15 ± 2.61 |
| RBC [106/μL] | 4.00–5.50 | 5 ± 0.31 | 4.37 ± 0.35 | 4.28 ± 0.56 |
| HGB [g/dl] | 12.00–16.00 | 14.56 ± 0.94 | 13.08 ± 1.05 | 12.67 ± 1.26 |
| PLT [103/μL] | 130–350 | 246.53 ± 50.17 | 255 ± 51 | 263 ± 67 |
| CRP [mg/L] | 0.00–5.00 | – | 8.29 ± 14.27 | 2.69 ± 2.24 |
| Glucose [mg/dL] | 70–110 | – | 99.8 ± 10.7 | 97 ± 5.66 |
| Creatinine [mg/dL] | 0.50–0.90 | – | 0.90 ± 0.13 | 0,79 ± 0.08 |
| ALT [U/I] | 0–31 | – | 23 ± 25 | 18 ± 11 |
| AST [U/I] | 0–32 | – | 16.47 ± 6.35 | 17 ± 4 |
| CSF analysis | ||||
| Cytosis [cells/µl] | 0–5 | – | 163 ± 99 | 102 ± 135 |
| Protein [mg/dl] | 15–45 | 75.13 ± 22.30 | 71.2 ± 65.11 | |